Oh- now I see- Provista specializes in female cancers, hence the name Videssa.
Who will market the male equivalent in the USA - GCDx under the LC Sentinel label? It seems confusing, since GCDx/LC Sentinel has not made any efforts to make its product gender specific up to now.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.